Home Search
epinephrine auto-injector - search results
If you're not happy with the results, please do another search
Windgap Medical Announces Partnership with ALK-Abelló to Commercialize Novel ‘Wet/Dry’ Epinephrine Auto-Injector
Novel auto-injector is designed to address many unmet patient needs like portability, temperature stability, ease-of-use, and long shelf-life.
Walgreens and Kaléo Expand Retail Pharmacy Collaboration to Include AUVI-q® 0.1 mg, the Only...
Full AUVI-Q product line available at Walgreens at no cost to eligible commercially insured patients and those who are eligible for kaleo’s patient support programs.
Stocking Epinephrine Auto-Injectors on Commercial Flights Found to be Cost-Effective
According to this study, base-case scenarios demonstrate the annual cost per passenger-at-risk would be $0.08.
Epinephrine Auto-injectors Retain High Levels of Epinephrine Years After Expiration Date, Study Finds
Study shows majority of epinephrine auto-injectors retained over 90% concentration of epinephrine years after expiration dates, regardless of the manufacturer.
Epinephrine Auto-Injector Companies Swept Up in 44 State Price Fixing Lawsuit
State prosecutors describe a price fixing scheme involving more than a dozen companies and as many executives responsible for sales, marketing, and pricing.
State Legislation Would Provide Epinephrine Auto-Injectors at No Cost to Patients
Bill named 'An Act To Save Lives through Epinephrine Autoinjector Accessibility'.
Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million
Windgap Medical is securing funding to continue development.
Symjepi List Price Undercuts Mylan and Teva EpiPen Generic Epinephrine Auto-Injectors
Symjepi launched with double-digit discount over competitors.
Study: Single Exposure to the Heat of a Car Can Lower Effective Dose of...
One exposure can render the effective epinephrine in an auto-injector below recommendations.
Editorial: Reasons to Not Accept as Gospel the Current Configurations of Epinephrine Auto-Injectors
Numerous studies indicate current auto-injector configurations may be less than optimal to the task of combating anaphylaxis for a significant portion of the population.